AKTX Akari Therapeutics Plc
Nasdaq · SEC CIK 1541157 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 64 since 2024-04-30, latest 2026-08-19 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Farag Kameel D. | Interim CFO | — | — |
| Patel Samir Rashmikant | Dir, 10% | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-17 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $7.52 | +1,728 | 23.3K | +8% | +$13.0K | |
| 2026-08-05 18:30 | 2026-07-16 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $11.50 | +1,130 | 21.6K | +6% | +$13.0K | |
| DMI | 2026-07-17 06:03 | 2026-07-07 | AKTX | Patel Samir Rashmikant | Dir, 10% | M - OptEx | $0.4307 | +22.5K | 98.2K | +30% | +$9,681 |
| M | 2026-06-25 20:06 | 2026-06-24 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $5.58 | +18.8K | 20.5K | +1,161% | +$105.0K |
| M | 2025-11-04 | 2025-11-01 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $0.75 | +58.6K | 32.0K | New | +$44.0K |
| 2025-10-24 | 2025-10-22 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $0.74 | +6,277 | 6,277 | New | +$4,645 | |
| M | 2025-08-29 | 2025-08-21+ | AKTX | Gaslightwala Abizer | CEO, Dir | P - Purchase | $0.9305 | +21.0K | 298.6K | +8% | +$19.5K |
| M | 2025-06-25 | 2025-06-23+ | AKTX | Gaslightwala Abizer | Pres, CEO, Dir | P - Purchase | $1.16 | +6,146 | 272.4K | +2% | +$7,120 |
| 2025-06-24 | 2025-06-20 | AKTX | Gaslightwala Abizer | Pres, CEO, Dir | P - Purchase | $1.20 | +10.0K | 271.4K | +4% | +$12.0K | |
| 2025-06-20 | 2025-06-17 | AKTX | Gaslightwala Abizer | Pres, CEO, Dir | P - Purchase | $1.20 | +15.0K | 261.4K | +6% | +$18.0K | |
| M | 2025-06-16 | 2025-06-12+ | AKTX | Gaslightwala Abizer | CEO, Dir | A - Grant | $1.21 | +45.0K | 246.4K | +22% | +$54.4K |
| 2025-06-12 | 2025-06-10 | AKTX | Gaslightwala Abizer | CEO, Dir | A - Grant | $1.27 | +20.0K | 201.4K | +11% | +$25.4K | |
| D | 2025-04-29 | 2025-03-06 | AKTX | Patel Sandip I | Dir | A - Grant | $1.12 | +44.6K | 496.5K | +10% | +$50.0K |
| D | 2025-03-10 | 2025-03-06 | AKTX | Bazemore Robert B | Dir | A - Grant | $1.12 | +44.6K | 44.6K | New | +$50.0K |
| D | 2025-03-10 | 2025-03-06 | AKTX | Prudo-Chlebosz Raymond | Dir | A - Grant | $1.12 | +446.4K | 2.48M | +22% | +$500.0K |
| D | 2025-03-10 | 2025-03-06 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $1.12 | +133.9K | 181.4K | +282% | +$150.0K |
| D | 2025-03-10 | 2025-03-06 | AKTX | Neal James R | Dir | A - Grant | $1.12 | +4,464 | 36.3K | +14% | +$5,000 |
| DI | 2025-03-10 | 2025-03-06 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $1.12 | +406.2K | 3.03M | +15% | +$455.0K |
| D | 2025-03-10 | 2025-03-06 | AKTX | Huh Hoyoung | Dir, 10% | A - Grant | $1.12 | +892.9K | 4.70M | +23% | +$1000.0K |
| A | 2025-02-07 | 2025-01-10 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $1.22 | +11.6K | 47.5K | +32% | +$14.2K |
| 2025-01-13 | 2025-01-10 | AKTX | Hombeck Torsten | CFO | A - Grant | $1.22 | +200 | 200 | New | +$244 | |
| 2025-01-13 | 2025-01-10 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $1.22 | +11.4K | 35.9K | +47% | +$14.0K | |
| 2025-01-10 | 2025-01-09 | AKTX | Neal James R | Dir | A - Grant | $0.00 | +8.00M | 32.22M | +33% | $0 | |
| 2025-01-07 | 2025-01-03 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $0.00 | +1.72M | 71.72M | +2% | $0 | |
| DI | 2025-01-07 | 2025-01-03 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +208.0K | 5.25B | +0.0% | $0 |
| MI | 2024-12-30 | 2024-12-26+ | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +3.60M | 5.25B | +0.1% | $0 |
| 2024-12-30 | 2024-12-27 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $0.00 | +40.00M | 70.00M | +133% | $0 | |
| 2024-12-27 | 2024-12-26 | AKTX | Gaslightwala Abizer | Dir | A - Grant | $0.00 | +30.00M | 30.00M | New | $0 | |
| I | 2024-12-27 | 2024-12-24 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +7.50M | 5.25B | +0.1% | $0 |
| I | 2024-12-26 | 2024-12-20 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +1.40M | 5.24B | +0.0% | $0 |
| 2024-12-26 | 2024-12-23 | AKTX | Neal James R | Dir | A - Grant | $0.00 | +2.00M | 24.22M | +9% | $0 | |
| I | 2024-12-26 | 2024-12-23 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +1.40M | 5.24B | +0.0% | $0 |
| D | 2024-12-03 | 2024-12-02 | AKTX | Prudo-Chlebosz Raymond | Dir | A - Grant | $0.00 | +419.29M | 4.08B | +11% | $0 |
| DI | 2024-12-03 | 2024-12-02 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +419.29M | 5.24B | +9% | $0 |
| I | 2024-11-18 | 2024-11-14 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | — | +1.40B | 4.82B | +41% | — |
| 2024-07-02 | 2024-06-30 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +91.40M | 91.40M | New | $0 | |
| D | 2024-06-04 | 2024-05-31 | AKTX | Prudo-Chlebosz Raymond | Dir | A - Grant | $0.00 | +1.33B | 3.66B | +57% | $0 |
| DI | 2024-06-04 | 2024-05-31 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $0.00 | +1.33B | 3.41B | +64% | $0 |
| 2024-05-03 | 2024-05-01 | AKTX | DICICCO WENDY F | Interim CFO | A - Grant | $0.00 | +158.47M | 158.47M | New | $0 | |
| 2024-04-30 | 2024-04-26 | AKTX | Jacques Rachelle Suzanne | CEO, Dir | A - Grant | $0.00 | +479.57M | 1.02B | +89% | $0 |
Purchase Sale Sale after option exercise All abbreviations